Fallopian tube papilloma

Summary

Fallopian tube papilloma (MONDO:0002534) is a disease. A subtype of fallopian tube benign neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	fallopian tube papilloma
Mondo ID	MONDO:0002534
DOID	DOID:3173
NCIT	C40112
UMLS	C1517123
MedGen	275874
GARD	0023155
Anatomy (UBERON)	UBERON:0003889
Is cancer (heuristic)	no

Also known as: fallopian tube papilloma · fallopian tube serous papilloma

Disease family

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › benign neoplasm › benign reproductive system neoplasm › benign female reproductive system neoplasm › fallopian tube benign neoplasm › fallopian tube papilloma

Related subtypes (3): fallopian tube leiomyoma, fallopian tube adenomatoid tumor, fallopian tube serous adenofibroma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.